Standard panels answer one question: are you a statistical outlier? CMiQCertified training gives you the framework to answer a more important one — how worried should your patient be, and what do you do about it?
An advanced credentialing program for clinicians who work with metabolic patients and want a more rigorous, evidence-based approach to assessment, interpretation, and clinical management.
Training enrollment is opening by metro area. Leave your details and we will be in touch with program information and availability.
Your information is used only to follow up about training availability.
Cardiometabolic disease is the defining clinical challenge of the next decade. The assessment framework most clinicians were trained on was not designed to find it early, characterize it accurately, or track its resolution.
The result is a clinical gap that shows up in every metabolic practice: patients with abnormal physiology and normal-looking labs. Conditions that are accumulating across systems simultaneously — invisible to any single marker, visible only to a framework that looks at the pattern.
ALT and AST are markers of cellular damage, not fat accumulation. Research shows 30–40% of confirmed fatty liver cases present with entirely normal enzyme values. The tool being used was never designed for the question being asked.
Fasting glucose and HbA1c identify established dysfunction. Insulin resistance — the primary metabolic driver of hepatic fat accumulation — is measurable years before glucose values become abnormal. Most standard panels never order fasting insulin.
Cardiometabolic risk accumulates across hepatic, metabolic, inflammatory, cardiovascular, and endocrine domains simultaneously. No single domain tells the complete story. A framework that evaluates the convergence is the only one that sees the whole picture.
The same multi-domain assessment that identifies risk should track its resolution. Without a structured follow-up protocol, clinical management becomes subjective and outcomes unverifiable. Reversal is measurable — but only if you are measuring the right things.
CMiQCertified training is structured as three stackable certifications, each expanding your clinical scope and the patient populations you are equipped to serve. Each level earns a distinct credential and directory listing badge.
The foundational certification. Covers comprehensive cardiometabolic assessment including the CMiQ panel architecture, the Physiologic Strain framework, the liver as central metabolic hub, and evidence-validated structured protocols for assessment, intervention, and retesting.
Required for all levelsAdvanced certification covering the intersection of thyroid function and cardiometabolic health. Includes comprehensive thyroid panel interpretation, the bidirectional relationship between thyroid and hepatic function, and integrated clinical management across both domains.
Requires Level 1Specialist certification for the hormonal and metabolic dynamics of perimenopause. Covers estradiol and progesterone dynamics, their interaction with thyroid and cardiometabolic function, and clinical management of the distinct risk profile of the perimenopausal transition.
Requires Levels 1 & 2higher all-cause mortality in fatty liver patients vs. the general population
Issa et al. · J Hepatol 2025
cardiovascular event risk — consistent across 52 studies and diverse populations
Zhong et al. · AJPC 2026
maximum practitioners listed per metro area in the patient directory
EndFattyLiver.com directory
CMiQCertified training is not limited to panel interpretation. The curriculum includes structured, evidence-validated therapeutic protocols designed to be deployed in tandem with testing — enabling clinicians to assess cardiometabolic physiology, apply targeted interventions, and retest against meaningful biomarker benchmarks to confirm clinical response.
These protocols are built on peer-reviewed clinical evidence and are designed for practical deployment within existing functional medicine and integrative practice frameworks. They are covered in depth as part of the CardioMetaboliQ Core certification.